Inhibitory effects of asiatic acid on 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 1, 2007, Pages 176-179

  Park, Byung Chul ^a   Paek, Seung Hwan ^a   Lee, Yoon Seok ^a   Kim, Seung Joo ^a   Lee, Eung Seok ^a   Choi, Han Gon ^a   Yong, Chul Soon ^a   Kim, Jung Ae ^a  

^a Yeungnam University   (South Korea)

Author keywords

12 O tetradecanoylphorbol 13 acetate (TPA); Asiatic acid; Carcinogenesis; Cyclooxygenase 2 (COX 2); Nitric oxide (NO)

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; AMINOGUANIDINE; ASIATIC ACID; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; THYMIDINE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; TUMOR GROWTH; TUMOR PROMOTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; FEMALE; MICE; MICE, INBRED ICR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PAPILLOMA; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRITERPENES;

EID: 33846069765     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.176     Document Type: Article

References (33)

1. Maquart F. X., Chastang F., Simeon A., Birembaut P., Gillery P., Wegrowski Y., Eur. J. Dermatol., 9, 289-296 (1999).
2. Lee Y. S., Jin D. Q., Beak S. M., Lee E. S., Kim, J. A., Eur. J. Pharmacol., 476, 173-178 (2003).
3. Lee M. K., Kim S. R., Sung S. H., Lim D., Kim H., Choi H., Park H. K., Je S., Ki Y. C., Res. Commun. Mol. Pathol. Pharmacol., 108, 75-86 (2000)
4. Jew S. S., Yoo C. H., Lim D. Y., Kim H., Mook-Jung I., Jung M. W., Choi H., Jung Y. H., Kim H., Park H. G., Bioorg. Med. Chem. Lett., 10, 119-121 (2000).
5. Dong M. S., Jung S. H., Kim H. J., Kim J. R., Zhao L. X., Lee E. S., Lee E. J., Yi J. B., Lee N., Cho Y. B., Kwak W. J., Park Y. I., Arch. Pharm. Res., 27, 512-517 (2004).
6. Hsu Y. L., Kuo P. L., Lin L. T., Lin C. C., J. Pharmacol. Exp. Ther., 313, 333-344 (2005).
7. Lee Y. S., Jin D. Q., Kwon E. J., Park S. H., Lee E. S., Jeong T. C., Nam D. H., Huh K., Kim, J. A., Cancer Lett., 186, 83-91 (2002).
8. Park B. C., Bosire K. O., Lee E. S., Lee Y. S., Kim J. A., Cancer Lett., 218, 81-90 (2005).
9. Yoshida M., Fuchigami M., Nagao T., Okabe H., Matsunaga K., Takata J., Karube Y., Tsuchihashi R., Kinjo J., Mihashi K., Fujioka T., Biol. Pharm. Bull., 28, 173-175 (2005).
10. Bunpo P., Kataoka K., Arimochi H., Nakayama H., Kuwahara T., Vinitketkumnuen U., Ohnishi Y., J. Med. Invest., 52, 65-73 (2005).
11. Kojima M., Morisaki T., Tsukahara Y., Uchiyama A., Matsunari Y., Mibu R., Tanaka M., J. Surg. Oncol., 70, 222-229 (1999).
12. Eijan A. M., Piccardo I., Riveros M. D., Sandes E. O., Porcella H., Jasnis M. A., Sacerdote De Lustig E., Malagrino H., Pasik L., Casabe A. R., J. Surg. Oncol., 81, 203-208 (2002).
13. Ahmad N., Srivastava R. C., Agarwal R., Mukhtar H., Biochem. Biophys. Res. Commun., 232, 328-331 (1997).
14. Ichinoe M., Mikami T., Shiraishi H., Okayasu I., Histopathology, 45, 612-618 (2004).
15. Larcher F., Murillas R., Bolontrade M., Conti C. J., Jorcano J. L., Oncogene, 17, 303-311 (1998).
16. Thomsen L. L., Miles D. W., Cancer Metastasis Rev., 17, 107-118 (1998).
17. Xie K., Fidler I. J., Cancer Metastasis Rev., 17, 55-75 (1998).
18. Salvemini D., Misko T. P., Masferrer J. L., Seibert K., Currie M. G., Needleman P., Proc. Natl. Acad. Sci. U.S.A., 90, 7240-7244 (1993).
19. Chun K. S., Cha H. H., Shin J. W., Na H. K., Park K. K., Chung W. Y., Surh Y. J., Carcinogenesis, 25, 445-454 (2004).
20. Mei J. M., Hord N. G., Winterstein D. F., Donald S. P., Phang J. M., FASEB J., 14, 1188-1201 (2000).
21. Fujita H., Koshida K., Keller E. T., Takahashi Y., Yoshimito T., Namiki M., Mizokami A., Prostate, 53, 232-240 (2002).
22. Ohno R., Yoshinaga K., Fujita T., Hasegawa K., Iseki H., Tsunozaki H., Ichikawa W., Nihei Z., Sugihara K., Cancer, 91, 1876-1881 (2001).
23. Ranger G. S., Jewell A., Thomas V., Mokbel K., J. Surg. Oncol., 88, 100-103 (2004).
24. Reddy B. S., Hirose Y., Lubet R., Steele V., Kelloff G., Paulson S., Seibert K., Rao C. V., Cancer Res., 60, 293-297 (2000).
25. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vainio H., Ristimaki A., Cancer Res., 58, 4997-5001 (1998).
26. Rao C. V., Indranie C., Simi B., Manning P. T., Connor J. R., Reddy B. S., Cancer Res., 62, 165-170 (2002).
27. Smart R. C., Huang M. T., Conney A. H., Carcinogenesis, 7, 1865-1870 (1986).
28. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R., Anal. Biochem., 126, 131-138 (1982).
29. Rao C. V., Mutat. Res., 555, 107-119 (2004).
30. Yagihashi N., Kasajima H., Sugai S., Matsumoto K., Ebina Y., Morita T., Murakami T., Yagihashi S., Virchows Arch., 436, 109-114 (2000).
31. Nosho K., Yoshida M., Yamamoto H., Taniguchi H., Adachi Y., Mikami M., Hinoda Y., Imai K., Carcinogenesis, 26, 892-899 (2005).
32. Chen B. C., Yu C. C., Lei H. C., Chang M. S., Hsu M. J., Huang C. L., Chen M. C., Sheu J. R., Chen T. F., Chen T. L., Inoue, H., Lin C. H., J. Immunol., 173, 5219-5228 (2004).
33. Chang M. S., Chen B. C., Yu M. T., Sheu J. R., Chen T. F., Lin C. H., Cell Signal., 17, 299-310 (2005).